Forest Hill Capital LLC Purchases 35,500 Shares of ZimVie Inc. (NASDAQ:ZIMV)

Forest Hill Capital LLC increased its stake in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 25.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 172,809 shares of the company's stock after purchasing an additional 35,500 shares during the quarter. ZimVie comprises about 1.9% of Forest Hill Capital LLC's portfolio, making the stock its 18th biggest position. Forest Hill Capital LLC owned 0.63% of ZimVie worth $2,411,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also modified their holdings of the company. Bank of New York Mellon Corp grew its holdings in ZimVie by 0.9% during the 4th quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company's stock worth $1,404,000 after acquiring an additional 943 shares during the period. Rhumbline Advisers grew its stake in shares of ZimVie by 3.0% during the fourth quarter. Rhumbline Advisers now owns 45,214 shares of the company's stock worth $631,000 after purchasing an additional 1,303 shares during the period. SG Americas Securities LLC lifted its stake in ZimVie by 15.7% in the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock valued at $155,000 after buying an additional 1,508 shares during the period. Principal Financial Group Inc. boosted its holdings in ZimVie by 9.8% during the fourth quarter. Principal Financial Group Inc. now owns 19,054 shares of the company's stock worth $266,000 after buying an additional 1,702 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in shares of ZimVie by 8.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 24,571 shares of the company's stock worth $343,000 after buying an additional 1,852 shares during the period. Institutional investors and hedge funds own 95.63% of the company's stock.

ZimVie Stock Down 0.9%

Shares of NASDAQ:ZIMV traded down $0.08 during midday trading on Thursday, reaching $8.64. The company had a trading volume of 68,868 shares, compared to its average volume of 214,130. ZimVie Inc. has a 1-year low of $8.56 and a 1-year high of $22.40. The stock has a market cap of $240.60 million, a PE ratio of -0.66 and a beta of 2.16. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57. The business's 50 day moving average price is $10.08 and its 200 day moving average price is $12.55.

ZimVie (NASDAQ:ZIMV - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.27 earnings per share for the quarter, topping analysts' consensus estimates of $0.21 by $0.06. The firm had revenue of $112.00 million for the quarter, compared to the consensus estimate of $113.10 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. Research analysts forecast that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms recently weighed in on ZIMV. B. Riley initiated coverage on shares of ZimVie in a research note on Thursday, April 10th. They set a "buy" rating and a $16.00 price objective on the stock. UBS Group decreased their price target on shares of ZimVie from $16.00 to $10.00 and set a "neutral" rating for the company in a report on Thursday. Finally, Needham & Company LLC restated a "hold" rating on shares of ZimVie in a report on Wednesday, April 9th.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.